-
Episode 113: Lessons Learned in Alzheimer Drug Development
19 Apr 2024 12:08 GMT
… breadth of neurology, including epilepsy, multiple sclerosis, Parkinson disease … Learned in Alzheimer Drug Development" features a … the perception of the FDA approval process, and what … antiamyloid therapies and available treatmentst
Click here to …
-
Impact of Antiepileptic Medications and Sex Hormones on Maternal and Child Outcomes in Epilepsy
18 Apr 2024 19:10 GMT
… pregnant women with epilepsy. Enzyme-inducing (EI) antiseizure medications (ASMs) have been … drugs influence the concentration of sex hormones in pregnant women with epilepsy … neurotic theories also influence neuronal development of children. MONEAD is a …
-
Woman suffers horrific reaction due to ibuprofen; develops scales on the skin, pus oozing from the eyes
18 Apr 2024 10:47 GMT
… epidermal necrolysis which requires immediate treatment at the hospital. Doctors examined … and noticed that she had developed conjunctivitis and discharge leaked out … medication. But the condition can also be triggered by antibiotics and epilepsy medication …
-
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s Disease
18 Apr 2024 10:30 GMT
… 3 TEMPO-3 adjunctive trial, demonstrating a statistically … Alzheimer’s disease psychosis, epilepsy, panic disorder and Parkinson … engaged in the development of treatments for relevant indications; … receive approval from the FDA or other regulatory authorities …
-
Antiepileptic Drugs Market Size, Share, Competitive Landscape and Industry Forecast, 2023-2032
18 Apr 2024 10:16 GMT
… more effective antiepileptic drugs. Continuous research efforts focus on developing medications with improved … Neurological Disorders: Antiepileptic drugs are not limited to epilepsy treatment alone. They are …
-
Urgent warning over shortages of life-saving drugs: Damning report reveals patients are at risk because of Britain's 'broken' medicine supply chain... so are stock of YOUR meds running low?
17 Apr 2024 23:39 GMT
… painkillers, antibiotics and epilepsy drugs as a 'shocking development'; that is … telling them that their medication is not available, it may … continue to get the treatments they need, which is … access to an alternative treatment until their usual product …
-
Analysis on the Efficacy of Cenobamate in Pediatric Patients With Refractory Epilepsy
17 Apr 2024 20:17 GMT
… FDA-approved antiseizure medication (ASM), in pediatric patients with drug-resistant epilepsy … Notably, treatment with cenobamate improved the rate of epilepsy-related inpatient … pediatric patients with refractory epilepsy.
Treatment options for patients with …
-
Small but mighty: The role of small-molecule drugs in disease treatment
17 Apr 2024 16:35 GMT
… which focuses on developing small-molecule drugs for psychiatric and … convenience associated with these drugs, treatment adherence can be better … effects taking small-molecule medications.
However, it is … as an oral treatment for chronic epilepsy and as an …
-
Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications
17 Apr 2024 12:30 GMT
… of orally administered medications. Prior to FDA approval to commercially … risk of developing TD increases with duration of treatment and … tumor.
In patients with epilepsy. Metoclopramide may increase the … of prescription drugs to the FDA.
Visit www.fda.gov…
-
Ventus Therapeutics Announces Results from Phase 1 Clinical Trial of VENT-02, a Novel, Orally Administered, Brain-Penetrant NLRP3 Inhibitor
17 Apr 2024 12:52 GMT
… computational chemistry platform, ReSOLVE™, to develop differentiated small molecule therapeutics, today … from this Phase 1 trial and our clinical development plans, we believe … a Phase 2 trial in patients with treatment-refractory epilepsy in 2025.Article …